- Discovery of platelet receptor and associated signalling mechanisms that are the basis of drug discovery programmes by pharmaceutical companies
- Collaboration with pharmaceutical sector towards the development of more effective anti-thrombotic agents or strategies
- Enterprise Fellow 2005
- Extensive worldwide media coverage of research publications
- Interviews with local and national print and broadcast media
- Public lectures, children's lectures (Reading and Royal Institution), children's workshops, and school visits
Jon Gibbins
-
+44 (0) 118 378 7082
-
Professor
- Professor of Cell Biology
- Director of the ICMR
- Leader of the University of Reading Platelet Biology Research Group
Teaching
- Part 3: Cardiovascular Disease
Research centres and groups
Local Collaborators
- Prof Ingo Bojak, Psychology
- Prof Anastasia Christakou, Psychology
- Prof Jonathan Hill, Psychology
- Prof David Oderberg, Philosophy
- Dr Chris Jones, School of Biological Sciences
- Dr Simon Clarke, School of Biological Sciences
- Dr Michael Fry, School of Biological Sciences
- Professor Julie Lovegrove, Food and Nutritional Sciences
- Dr Marcus Tindall, Department of Mathematics and Statistics
- Dr Fazil Baksh, Department of Mathematics and Statistics
International Collaborators
Extensive international collaborations include colleagues at
- Sick Kids Hospital, University of Toronto, Canada
- University of British Columbia, Vancouver, Canada
- Blood Center of Wisconsin, Milwaukee, USA
- Emory University, Atlanta, USA
- University of Pennsylvania, Philadelphia, USA
- Temple University, Philadelphia, USA
- Harvard Medical School, Boston, USA
- Kyoto Sangyo University, Kyoto, Japan
- Australian Centre for Blood Diseases, Monash University, Australia
- School for Cardiovascular Diseases, University of Maastricht, Netherlands
- University of Marseille, France
- Max Plank Institute for Molecular Biomedicine, Münster, Germany
- King Saud University, Riyadh, Saudi Arabia
National Collaborators
Our research is supported by extensive formal and informal collaborations with colleagues at the Wellcome Sanger Institute, Cambridge and at the Universities of
- Cambridge
- Leicester
- Birmingham
- Bristol
- Hull
- Surrey
- Nottingham
- King's College London
- Imperial College London
Research projects
- Funding from British Heart Foundation, MRC, BBSRC, Heart Research UK, and pharmaceutical companies
- Programme grants from British Heart Foundation and MRC
- Understanding of the molecular mechanisms that regulate the function of platelets in haemostasis and thrombosis
- Development of new strategies for the prevent of thrombosis
- Cell signalling, specialist assays of haematological function, in vivo analysis of thrombosis and its prevention
- Development of a mathematical model of platelet signalling and function - the Virtual Platelet - for in silico experimentation, drug discovery and diagnosis.
- Founding director of the ICMR, which brings together the distinctive range of research expertise across the University to enable us impact on reducing the burden of cardiovascular diseases and the metabolic conditions from which they develop, through disease prevention and treatment.
Awards and honours
Esteem Factors
- Platelet Society - Chair: 2019-2021
- Heart Research UK- Chair, Novel and Emerging Technologies Panel 2015-2022
- Royal Society Newton Advanced Fellowships Panel: 2018 - 2021
- Full editorial board member, British Journal of Pharmacology: 2014-2020
- Visiting Professor, King Saud University, Riyadh, Saudi Arabia 2011-2014
- Full editorial board member, Journal of Biological Chemistry: 2008-2013
- British Heart Foundation Project Grants Committee: 2009-2012
- John French Lecture 2008 - British Atherosclerosis Society
Impact, enterprise and outreach